These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 10999810

  • 1. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects.
    Legrain S, Massien C, Lahlou N, Roger M, Debuire B, Diquet B, Chatellier G, Azizi M, Faucounau V, Porchet H, Forette F, Baulieu EE.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3208-17. PubMed ID: 10999810
    [Abstract] [Full Text] [Related]

  • 2. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W, Haas J, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
    [Abstract] [Full Text] [Related]

  • 3. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F, Bélanger A, Cusan L, Candas B.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men.
    Acacio BD, Stanczyk FZ, Mullin P, Saadat P, Jafarian N, Sokol RZ.
    Fertil Steril; 2004 Mar; 81(3):595-604. PubMed ID: 15037408
    [Abstract] [Full Text] [Related]

  • 5. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W, Justl HG, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [Abstract] [Full Text] [Related]

  • 6. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337
    [Abstract] [Full Text] [Related]

  • 7. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
    Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendörfer RA, Pirke KM, Kirschbaum C.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2363-7. PubMed ID: 9215320
    [Abstract] [Full Text] [Related]

  • 8. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 9. Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
    Martel C, Labrie F, Archer DF, Ke Y, Gonthier R, Simard JN, Lavoie L, Vaillancourt M, Montesino M, Balser J, Moyneur É, other participating members of the Prasterone Clinical Research Group.
    J Steroid Biochem Mol Biol; 2016 May; 159():142-53. PubMed ID: 26972555
    [Abstract] [Full Text] [Related]

  • 10. Effects of a 3-week dehydroepiandrosterone administration on sleep, sex steroids and multiple 24-h hormonal profiles in postmenopausal women: a pilot study.
    Caufriez A, Leproult R, L'Hermite-Balériaux M, Kerkhofs M, Copinschi G.
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):716-24. PubMed ID: 23488643
    [Abstract] [Full Text] [Related]

  • 11. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA.
    Labrie F, Cusan L, Gomez JL, Martel C, Bérubé R, Bélanger P, Chaussade V, Deloche C, Leclaire J.
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):1-9. PubMed ID: 18359622
    [Abstract] [Full Text] [Related]

  • 12. Dehydroepiandrosterone secretion in healthy older men and women: effects of testosterone and growth hormone administration in older men.
    Muniyappa R, Wong KA, Baldwin HL, Sorkin JD, Johnson ML, Bhasin S, Harman SM, Blackman MR.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4445-52. PubMed ID: 16926252
    [Abstract] [Full Text] [Related]

  • 13. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age.
    Guazzo EP, Kirkpatrick PJ, Goodyer IM, Shiers HM, Herbert J.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3951-60. PubMed ID: 8923843
    [Abstract] [Full Text] [Related]

  • 14. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue.
    Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharrière O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F.
    Proc Natl Acad Sci U S A; 2000 Apr 11; 97(8):4279-84. PubMed ID: 10760294
    [Abstract] [Full Text] [Related]

  • 15. Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey.
    Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F.
    J Clin Endocrinol Metab; 2003 Sep 11; 88(9):4293-302. PubMed ID: 12970301
    [Abstract] [Full Text] [Related]

  • 16. Serum steroids remain within the same normal postmenopausal values during 12-month intravaginal 0.50% DHEA.
    Ke Y, Gonthier R, Simard JN, Archer D, Lavoie L, Martel C, Vaillancourt M, Labrie F.
    Horm Mol Biol Clin Investig; 2015 Dec 11; 24(3):117-29. PubMed ID: 26509785
    [Abstract] [Full Text] [Related]

  • 17. Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults.
    Frye RF, Kroboth PD, Kroboth FJ, Stone RA, Folan M, Salek FS, Pollock BG, Linares AM, Hakala C.
    J Clin Pharmacol; 2000 Jun 11; 40(6):596-605. PubMed ID: 10868310
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of oral dehydroepiandrosterone (DHEA) in the ovariectomised cynomolgus monkey.
    Leblanc M, Labrie C, Bélanger A, Candas B, Labrie F.
    J Steroid Biochem Mol Biol; 2002 Jun 11; 81(2):159-64. PubMed ID: 12137806
    [Abstract] [Full Text] [Related]

  • 19. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
    Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B.
    J Clin Endocrinol Metab; 1997 Aug 11; 82(8):2396-402. PubMed ID: 9253307
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.
    Ke Y, Labrie F, Gonthier R, Simard JN, Bergeron D, Martel C, Vaillancourt M, Montesino M, Lavoie L, Archer DF, Balser J, Moyneur E, other participating Members of the Prasterone Clinical Research Group.
    J Steroid Biochem Mol Biol; 2015 Nov 11; 154():186-96. PubMed ID: 26291918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.